Companies: 10,795·Total market cap: $144.5T
Provention Bio, Inc.

Provention Bio, Inc.

PRVBNASDAQHealthcare
$24.98
+$0.00(+0.00%)
Market Cap$2.4B
P/E Ratio—
52W High$25.0
52W Low$3.185
SEC Filings

Provention Bio, Inc. (PRVB) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001695357 · PRVB · NASDAQ · as of Jun 8, 2026

Filing snapshot

426
Total Filings
15-12G
Latest Form
2023-05-08
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001695357 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-03-29
Fiscal Year End
Mar 29, 2023
Accession No.
0001493152-23-009516
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001695357 · Accession 0001493152-23-009516

Latest Key Filings

10-QQuarterly Report
Quarterly Report
2022-11-03
View 10-Q on SEC
8-KCurrent Report
Current Report
2023-04-27Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2023-05-08
View
EFFECTEFFECT
EFFECT
2023-04-28
View
EFFECTEFFECT
EFFECT
2023-04-28
View
EFFECTEFFECT
EFFECT
2023-04-28
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2023-04-28
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
S-8 POSS-8 POS
S-8 POS
2023-04-27
View
POS AMPOS AM
POS AM
2023-04-27
View
POS AMPOS AM
POS AM
2023-04-27
View
Showing 1–15 of 259 filingsForm 4 / 144 hidden· 426 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001695357  |  Exchange: NASDAQ · Healthcare

Provention Bio, Inc. (NASDAQ: PRVB) has submitted 426 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001695357, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Provention Bio, Inc.'s most comprehensive regulatory disclosure. The most recent Provention Bio, Inc. 10-K was filed on 2023-03-29 for fiscal year ending 2023. Historical PRVB 10-K annual reports are available from 2017 through 2023.

Investors researching Provention Bio, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
MOR SEC Filings →MORF SEC Filings →KDNY SEC Filings →MYOV SEC Filings →LBPH SEC Filings →DICE SEC Filings →DCPH SEC Filings →BLU SEC Filings →
→ PRVB Financials→ PRVB Earnings→ PRVB Insider Trades

Frequently Asked Questions

PRVB SEC Filings · 8 questions

Provention Bio, Inc. (PRVB) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 426 filings and access original documents at no cost. Provention Bio, Inc.'s CIK is 0001695357.

PRVB SEC filingsProvention Bio, Inc. SEC documentsfind PRVB 10-K